NCT00434473View on ClinicalTrials.gov

IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

December 31, 2009

Conditions
Sickle Cell DiseaseVaso-occlusive CrisisAcute Chest Syndrome
Interventions
DRUG

A-001

A-001

OTHER

Placebo

Placebo

Trial Locations (6)

11203

SUNY Downstate Medical Center, Brooklyn

20060

Howard University Hospital, Washington D.C.

23219

Virginia Commonwealth University, Richmond

27713

Duke University Comprehensive Sickle Cell Center, Durham

30342

Children's Healthcare of Atlanta, Atlanta

60614

Children's Memorial Hospital, Chicago

Sponsors
All Listed Sponsors
lead

Anthera Pharmaceuticals

INDUSTRY

NCT00434473 - IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome | Biotech Hunter | Biotech Hunter